June 25, 2020 / 3:25 PM / 17 days ago

BRIEF-Genprex Receives USAN Approval Of Non-Proprietary Name For Lead Drug Candidate

June 25 (Reuters) - Genprex Inc:

* GENPREX RECEIVES USAN APPROVAL OF NON-PROPRIETARY NAME FOR LEAD DRUG CANDIDATE

* GENPREX INC - LEAD DRUG CANDIDATE FOR NSCLC NOW REFERRED TO AS QUARATUSUGENE OZEPLASMID OR GPX-001

* GENPREX INC - COMPANY REBRANDS USE OF ONCOPREX NAME FOR NANOPARTICLE DELIVERY PLATFORM Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below